Lyfebulb Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

  • Investments
  • 9

Lyfebulb General Information

Description

Operator of an online digital platform focused on reducing the burden of chronic disease through the power of the patient. The company bridges the gap between patient communities and the healthcare industry by working directly with patients and care partners to generate insights, build new solutions, and bring revolutionary products to market through education, innovation, and connectivity.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • 654 Madison Avenue
  • Suite 1501
  • New York, NY 10065
  • United States
Primary Industry
Media and Information Services (B2B)
Other Industries
Other Healthcare Services
Parent Company
Corporate Office
  • 654 Madison Avenue
  • Suite 1501
  • New York, NY 10065
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lyfebulb Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Lyfebulb‘s full profile, request access.

Request a free trial

Lyfebulb Investments (9)

Lyfebulb’s most recent deal was a Grant with Coral Genomics for . The deal was made on 01-Sep-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Coral Genomics 01-Sep-2021 Grant Biotechnology
Nephrosant 14-May-2021 Grant Diagnostic Equipment
Evolution Devices 12-Mar-2021 Grant Therapeutic Devices
Oncoheroes Biosciences 31-Jan-2020 Grant Drug Discovery
BITT (Drug Discovery) 30-Jan-2020 Grant Drug Discovery
You’re viewing 5 of 9 investments. Get the full list »

Lyfebulb Exits (4)

Lyfebulb’s most recent exit was on 01-Sep-2021 from Coral Genomics. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Coral Genomics 01-Sep-2021 Completed
  • 2 buyers
Nephrosant 14-May-2021 Completed
  • 2 buyers
BeCareLink 10-May-2019 Completed
  • 2 buyers
MedAngel 08-Nov-2017 Grant Completed
To view Lyfebulb’s complete exits history, request access »

Lyfebulb FAQs

  • When was Lyfebulb founded?

    Lyfebulb was founded in 2014.

  • Where is Lyfebulb headquartered?

    Lyfebulb is headquartered in New York, NY.

  • What industry is Lyfebulb in?

    Lyfebulb’s primary industry is Media and Information Services (B2B).

  • Is Lyfebulb a private or public company?

    Lyfebulb is a Private company.

  • What is Lyfebulb’s current revenue?

    The current revenue for Lyfebulb is .

  • When was Lyfebulb acquired?

    Lyfebulb was acquired on 05-Mar-2024.

  • Who acquired Lyfebulb?

    Lyfebulb was acquired by Patient Care America.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process